期刊文献+

f/tPSA比值、PSA密度、PSA移行带密度在tPSA灰区前列腺偶发癌诊断中的意义 被引量:1

Value of F/t PSA ratio,PSA density and PSA density of transitional zone in the diagnosis of occasional prostate cancer located in tPSA grey area
下载PDF
导出
摘要 目的探讨血清f/tPSA比值、PSA密度、PSA移行带密度在tPSA位于灰区时前列腺癌诊断中的意义。方法 tPSA位于4~10ng/ml的前列腺增生患者112例,术前经前列腺穿刺活检均证实为前列腺增生,行TURP术后病理证实21例为前列腺偶发癌患者。回顾性分析该21例前列腺偶发癌患者和其余前列腺增生患者间的血清f/tPSA比值、PSA密度、PSA移行带密度,并进行统计学分析,以了解其在tPSA灰区前列腺偶发癌诊断中的意义。结果前列腺偶发癌组和BPH组血清f/tPSA比值分别为0.13±0.03、0.21±0.04;PSAD分别为0.20±0.05ng/ml2、0.12±0.04ng/ml2;PSATZ分别为0.38±0.06ng/ml2、0.21±0.05ng/ml2;两组在以上三个检测指标上差异具有显著性(P<0.05)。以0.15ng/ml2为截断点则PSAD灵敏性为76.115%,特异性为69.146%;以0.35ng/ml2为截断点则PSATZ灵敏性为60.642%,特异性为93.943%。结论 f/tPSA比值、PSAD、PSATZ对前列腺偶发癌的诊断具有重要价值,其中尤以PSATZ更具预测价值。 Objective To study the importance of serum f/t prostate specific antigen ratio(f/t PSA),prostate specific antigen density(PSAD),prostate specific antigen density of transition zone(PSADTZ) when the tPSA located in grey area of prostate cancer.Methods One hundred and twelve cases with prostatic hyperplasia of tPSA located in 4~10 ng/ml were proved by prostatic needle biopsy preoperatively.After TURP,21 cases were diagnosed as occasional prostate cancer by pathology.21 cases with occasional prostate cancer and other cases with the prostatic hyperplasia patients were retrospectively analyzed by serum f/t PSA ratio,PSAD,PSA DTZ.And the statistical analysis was used to understand the importance in the tPSA grey area in the diagnosis of occasional prostate cancer.Results The prostate cancer group and the BPH group had the f/t serum PSA ratio 0.13±0.03 ng/ml and 0.21±0.04 ng/ml respectively.PSAD was 0.20±0.05 ng/ml2,0.12±0.04 ng/ml2 respectively.PSADTZ was 0.38 + 0.06 ng/ml2,0.21 + 0.05 ng/ml2 respectively.Two groups in the above three monitoring indexes had significant difference(P0.05).With 0.15 ng/ml2 for truncated point of PSAD had sensitivity of 76.115%,specificity of 69.146%;With 0.35 ng/ml2 for truncated point of PSADTZ had sensitivity of 60.642%,specificity of 93.943%.Conclusion f/t PSA ratio,PSAD,PSADTZ possess important value for the diagnosis of prostate cancer,especially the PSADTZ has more predictive value.
出处 《岭南现代临床外科》 2011年第1期63-65,共3页 Lingnan Modern Clinics in Surgery
基金 盐田区科技计划项目(08w01) 广东省自然科学基金(10151008901000070) 广东省医学科学基金(A2008178)
关键词 前列腺增生症 前列腺偶发癌 前列腺特异性抗原 前列腺特异性抗原密度 前列腺移行区特异性抗原密度 Prostatic hyperplasia Occasional prostatic cancer Prostatic specific antigen Prostatic specific antigen density Protatic antigen density of transitional zene
  • 相关文献

参考文献8

  • 1马潞林,邱敏.低PSA型前列腺癌PSA不增高的原因分析及诊断策略[J].中华腔镜泌尿外科杂志(电子版),2010,4(4):1-3. 被引量:3
  • 2计国义,王伟华,赵微,刘喜春,赵雪俭.PSA、PSAD、f/tPSA在早期前列腺癌诊断作用的研究[J].中国实验诊断学,2009,13(1):100-102. 被引量:14
  • 3林延双,梁建波,何大光,玉海,韦华玉,蓝志相.TPSAF/T比值PSAD在早期前列腺癌诊断作用中的比较研究[J].临床泌尿外科杂志,2006,21(11):852-854. 被引量:7
  • 4Benson M C,Whang I S,Pantuck A,et al.Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. The Journal of Urology . 1992
  • 5Kalish J,Cooner W H,Graham S D Jr.Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume( PSAD) in detecting adenocarcinoma of the prostate. Urology . 1994
  • 6Martinez JM,Garcia MF.Value of prostate-specific antigendensity and transitional-zone prostate-specific antigen densityin the diagnosis of prostate cancer. Acras Urol Esp . 2003
  • 7Djavan B,Zlotta AR,Byttebier G,et al.Prostate specific antigen density of the transition zone for early detection of prostate cancer. Journal d Urologie . 1998
  • 8Zlotta AR,Djavan B,Marberger M,et al.Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. Journal d Urologie . 1997

二级参考文献31

  • 1陈斌鸿,陈社安.复合型PSA与总PSA比值在前列腺癌诊断中的应用[J].中国实验诊断学,2005,9(2):210-212. 被引量:5
  • 2林延双,梁建波,何大光,刘时才,苏依莱,韦华玉.血清PSA测定与前列腺癌病理组织学类型关系的研究[J].中国男科学杂志,2006,20(8):45-48. 被引量:4
  • 3陈伟杰,吴宗林,唐炯.血清PSA正常的进展型前列腺癌2例报告[J].中华男科学杂志,2007,13(6):559-560. 被引量:3
  • 4Smith DS. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection [ J ]. J Urol, 1999,151 : 1283.
  • 5furuya Y,Akakura k,lto H. Value of f/tPSA ratio for detection and staging of PCa[ J ]. International Joumal of Clinical Oncology,2000,5( 1 ) :8.
  • 6Kuwahara M, Toehigi T, Kawamura S, et al. Mass screening for prostate cancer:a oxnparative study in Natori, Japan and Changchun, China[J]. Urology,2003,61 (1) : 137.
  • 7Filella X, Truan D. Aleover J, et al. Comparison of several combinations of fl~SA, cPSA, and tPSAin the diagnosis of PCain patients with urologic symptorns[J]. Journal of Urology,2004,63(6) :1103.
  • 8Pelzer A E,Volgger H,Bektic J,et al.The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels.BJU Int,2005,96(7):995-998.
  • 9Bangma CH,Kranse R,Blijenberg BG,et al.The value of screening tests in the detection of prostate cancer.Part I:Results of a retrospective evaluation of 1726 men.J Urol,1995,46(6):773-778.
  • 10Thompson M,Pauler DK,Goodman PJ,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level 《 or =4.0 ng per milliliter.N Engl J Med,2004,350(22):2239-2248.

共引文献21

同被引文献13

  • 1Kim JS, Ryu JG, Kim JW, et al. Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer [J]? Int Braz J Urol, 2015, 41(2): 258-264.
  • 2Pezaro C, Woo HI-I, Davis ID. Prostate cancer: measuring PSA [J]. Intern Med J, 2014, 44(5): 433-440.
  • 3Kirby R. Optimising the management of early prostate cancer [J]. Practitioner, 2014, 258(1770) : 15-18.
  • 4Andriole GL, Crawford ED, Grubb RL 3rd, Mortality results from a randomized prostate-cancer screening trial [J]. N Engl J Med, 2009, 360(13): 1310-1319.
  • 5Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA Guideline [J]. Urol, 2013, 5347 (13) : 4308-4315.
  • 6Janane A, Hajji F, Ismail T, et al. Usefulness and predictive value of PSA levels between 2 and 4 ng/ml [J]. Actas Urol Esp, 2012, 36(2): 93-98.
  • 7Catalona WJ, Partin AW, Finlay JA, et al. Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/ml and digital rectal examination is not suspicious for prostate cancer: an alternative model[J]. Urology, 1999, 54(1): 220- 224.
  • 8Heidegger I, Klocker H, Pichler R, et al. PSA Isoforms' velocities for early diagnosis of prostate cancer[J]. Anticancer Res, 2015, 35(6): 3567-3570.
  • 9高双友,宋蕊,阚志生,刘俊江,温英武,李守宾.血清sE-cad、TPSA在前列腺癌诊断中的意义[J].中国现代医学杂志,2011,21(1):145-148. 被引量:4
  • 10高双友,宋蕊,李连印,温英武,黄克岭.(F/T)/PSAD在血清PSA<4ng/mL前列腺癌诊断中的应用[J].现代泌尿外科杂志,2011,16(1):74-75. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部